cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 26080906)

Published in Am J Transplant on June 16, 2015

Authors

K J Tinckam1,2, R Liwski3, D Pochinco4, M Mousseau2, A Grattan2, P Nickerson2,4,5, P Campbell6

Author Affiliations

1: Division of Nephrology, Department of Medicine and HLA Laboratory, University Health Network, University of Toronto, Toronto, Ontario, Canada.
2: Canadian Blood Services, Organ and Tissue Donation and Transplantation, Ottawa, Ontario, Canada.
3: Department of Pathology and Laboratory Medicine, Dalhousie University, Nova Scotia, Canada.
4: Transplant Immunology Laboratory, Diagnostic Services Manitoba, Winnipeg, Manitoba, Canada.
5: Section of Nephrology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
6: Division of Medicine and Laboratory Medicine, University of Alberta, Edmonton, Alberta, Canada.

Articles cited by this

High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol (2007) 3.03

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant (2009) 2.21

Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J Heart Lung Transplant (2012) 2.01

New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. J Am Soc Nephrol (2014) 1.98

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens (2003) 1.81

Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics (1991) 1.26

Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant (2010) 1.24

The Canadian kidney paired donation program: a national program to increase living donor transplantation. Transplantation (2015) 1.02

Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program. Am J Transplant (2014) 1.01

Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. Transpl Immunol (2007) 0.99

The DQ barrier: improving organ allocation equity using HLA-DQ information. Transplantation (2013) 0.95

The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. Transplantation (2010) 0.93

The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients. Am J Transplant (2014) 0.92

The calculated panel reactive antibody policy: an advancement improving organ allocation. Curr Opin Organ Transplant (2011) 0.89

DQA1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol (1994) 0.88

HLA-DQ barrier: effects on cPRA calculations. Transplantation (2013) 0.87

First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry. Hum Immunol (2014) 0.84